A previous study demonstrated that CH protects against renal tubular damage by reducing the levels of the proinflammatory cytokines IL1β and IL6, as well as those of apoptosis markers, in a renal ischemia model [23]. The gene discussed is IL1B; the disease is cyclic hematopoiesis.